Literature DB >> 27761709

Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy.

Salvatore Nigro1, Gennarina Arabia2, Angelo Antonini3, Luca Weis3, Andrea Marcante3, Alessandro Tessitore4,5, Mario Cirillo4,5, Gioacchino Tedeschi4,5, Stefano Zanigni6,7, Giovanna Calandra-Buonaura7,8, Caterina Tonon6,7, Gianni Pezzoli9, Roberto Cilia9, Mario Zappia10, Alessandra Nicoletti10, Calogero Edoardo Cicero10, Michele Tinazzi11, Pierluigi Tocco11, Nicolò Cardobi12, Aldo Quattrone13,14.   

Abstract

OBJECTIVES: To investigate the reliability of a new in-house automatic algorithm for calculating the Magnetic Resonance Parkinsonism Index (MRPI), in a large multicentre study population of patients affected by progressive supranuclear palsy (PSP) or Parkinson's disease (PD), and healthy controls (HC), and to compare the diagnostic accuracy of the automatic and manual MRPI values.
METHODS: The study included 88 PSP patients, 234 PD patients and 117 controls. MRI was performed using both 3T and 1.5T scanners. Automatic and manual MRPI values were evaluated, and accuracy of both methods in distinguishing PSP from PD and controls was calculated.
RESULTS: No statistical differences were found between automated and manual MRPI values in all groups. The automatic MRPI values differentiated PSP from PD with an accuracy of 95 % (manual MRPI accuracy 96 %) and 97 % (manual MRPI accuracy 100 %) for 1.5T and 3T scanners, respectively.
CONCLUSION: Our study showed that the new in-house automated method for MRPI calculation was highly accurate in distinguishing PSP from PD. Our automatic approach allows a widespread use of MRPI in clinical practice and in longitudinal research studies. KEY POINTS: • A new automatic method for calculating the MRPI is presented. • Automatic MRPI values are in good agreement with manual values. • Automatic MRPI can distinguish patients with PSP from patients with PD. • The automatic method overcomes MRPI application limitations in routine practice. • The automatic method may allow a more widespread use of MRPI.

Entities:  

Keywords:  Automatic segmentation; Magnetic Resonance Parkinsonism Index; Neurodegenerative disease; Parkinson’s disease; Progressive supranuclear palsy

Mesh:

Year:  2016        PMID: 27761709     DOI: 10.1007/s00330-016-4622-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  28 in total

1.  MRI measurements predict PSP in unclassifiable parkinsonisms: a cohort study.

Authors:  M Morelli; G Arabia; F Novellino; M Salsone; L Giofrè; F Condino; D Messina; A Quattrone
Journal:  Neurology       Date:  2011-08-10       Impact factor: 9.910

2.  Penguins and hummingbirds: midbrain atrophy in progressive supranuclear palsy.

Authors:  Klaus Gröschel; Andreas Kastrup; Irene Litvan; Jörg B Schulz
Journal:  Neurology       Date:  2006-03-28       Impact factor: 9.910

3.  Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy.

Authors:  Anna Hussl; Philipp Mahlknecht; Christoph Scherfler; Regina Esterhammer; Michael Schocke; Werner Poewe; Klaus Seppi
Journal:  Mov Disord       Date:  2010-10-30       Impact factor: 10.338

Review 4.  Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism.

Authors:  Anna Hotter; Regina Esterhammer; Michael F H Schocke; Klaus Seppi
Journal:  Mov Disord       Date:  2009       Impact factor: 10.338

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.

Authors:  Giuseppe Nicoletti; Caterina Tonon; Raffaele Lodi; Francesca Condino; David Manners; Emil Malucelli; Maurizio Morelli; Fabiana Novellino; Sandra Paglionico; Pierluigi Lanza; Demetrio Messina; Paolo Barone; Letterio Morgante; Mario Zappia; Bruno Barbiroli; Aldo Quattrone
Journal:  Mov Disord       Date:  2008-12-15       Impact factor: 10.338

7.  The midbrain to pons ratio: a simple and specific MRI sign of progressive supranuclear palsy.

Authors:  Luke A Massey; Hans R Jäger; Dominic C Paviour; Sean S O'Sullivan; Helen Ling; David R Williams; Constantinos Kallis; Janice Holton; Tamas Revesz; David J Burn; Tarek Yousry; Andrew J Lees; Nick C Fox; Caroline Micallef
Journal:  Neurology       Date:  2013-04-24       Impact factor: 9.910

8.  Effect of aging on magnetic resonance measures differentiating progressive supranuclear palsy from Parkinson's disease.

Authors:  Maurizio Morelli; Gennarina Arabia; Demetrio Messina; Basilio Vescio; Maria Salsone; Carmelina Chiriaco; Paolo Perrotta; Federico Rocca; Giuseppe Lucio Cascini; Gaetano Barbagallo; Salvatore Nigro; Aldo Quattrone
Journal:  Mov Disord       Date:  2014-02-26       Impact factor: 10.338

9.  Magnetic resonance parkinsonism index in progressive supranuclear palsy and vascular parkinsonism.

Authors:  Giovanni Mostile; Alessandra Nicoletti; Calogero Edoardo Cicero; Tiziana Cavallaro; Elisa Bruno; Valeria Dibilio; Antonina Luca; Giorgia Sciacca; Loredana Raciti; Donatella Contrafatto; Ignazio Chiaramonte; Mario Zappia
Journal:  Neurol Sci       Date:  2016-01-28       Impact factor: 3.307

10.  Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.

Authors:  Gilbert Bensimon; Albert Ludolph; Yves Agid; Marie Vidailhet; Christine Payan; P Nigel Leigh
Journal:  Brain       Date:  2008-11-23       Impact factor: 13.501

View more
  22 in total

1.  Track density imaging in progressive supranuclear palsy: A pilot study.

Authors:  Salvatore Nigro; Maria Giovanna Bianco; Gennarina Arabia; Maurizio Morelli; Rita Nisticò; Fabiana Novellino; Maria Salsone; Antonio Augimeri; Aldo Quattrone
Journal:  Hum Brain Mapp       Date:  2018-11-26       Impact factor: 5.038

Review 2.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

Review 3.  Emerging Diagnostic and Therapeutic Strategies for Tauopathies.

Authors:  David Coughlin; David J Irwin
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

4.  Progressive Supranuclear Palsy and Corticobasal Degeneration.

Authors:  David G Coughlin; Dennis W Dickson; Keith A Josephs; Irene Litvan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Magnetic resonance imaging for the diagnosis of Parkinson's disease.

Authors:  Beatrice Heim; Florian Krismer; Roberto De Marzi; Klaus Seppi
Journal:  J Neural Transm (Vienna)       Date:  2017-04-04       Impact factor: 3.575

6.  Normative Data for Brainstem Structures, the Midbrain-to-Pons Ratio, and the Magnetic Resonance Parkinsonism Index.

Authors:  S T Ruiz; R V Bakklund; A K Håberg; E M Berntsen
Journal:  AJNR Am J Neuroradiol       Date:  2022-04-07       Impact factor: 3.825

7.  Toward More Accessible Fully Automated 3D Volumetric MRI Decision Trees for the Differential Diagnosis of Multiple System Atrophy, Related Disorders, and Age-Matched Healthy Subjects.

Authors:  Jisoo Kim; Geoffrey S Young; Andrew S Willett; Ariana T Pitaro; Grace F Crotty; Merlyne Mesidor; Kristie A Jones; Camden Bay; Min Zhang; Mel B Feany; Xiaoyin Xu; Lei Qin; Vikram Khurana
Journal:  Cerebellum       Date:  2022-09-26       Impact factor: 3.648

8.  Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study.

Authors:  Salvatore Nigro; Angelo Antonini; David E Vaillancourt; Klaus Seppi; Roberto Ceravolo; Antonio P Strafella; Antonio Augimeri; Andrea Quattrone; Maurizio Morelli; Luca Weis; Eleonora Fiorenzato; Roberta Biundo; Roxana G Burciu; Florian Krismer; Nikolaus R McFarland; Christoph Mueller; Elke R Gizewski; Mirco Cosottini; Eleonora Del Prete; Sonia Mazzucchi; Aldo Quattrone
Journal:  Mov Disord       Date:  2020-02-24       Impact factor: 10.338

Review 9.  Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

Authors:  Jennifer L Whitwell; Günter U Höglinger; Angelo Antonini; Yvette Bordelon; Adam L Boxer; Carlo Colosimo; Thilo van Eimeren; Lawrence I Golbe; Jan Kassubek; Carolin Kurz; Irene Litvan; Alexander Pantelyat; Gil Rabinovici; Gesine Respondek; Axel Rominger; James B Rowe; Maria Stamelou; Keith A Josephs
Journal:  Mov Disord       Date:  2017-05-13       Impact factor: 10.338

10.  Magnetic Resonance Imaging and Neurofilament Light in the Differentiation of Parkinsonism.

Authors:  Derek B Archer; Trina Mitchell; Roxana G Burciu; Jing Yang; Salvatore Nigro; Aldo Quattrone; Andrea Quattrone; Andreas Jeromin; Nikolaus R McFarland; Michael S Okun; David E Vaillancourt
Journal:  Mov Disord       Date:  2020-05-01       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.